Imunon Inc (IMNN)
1.39
-0.02
(-1.42%)
USD |
NASDAQ |
May 16, 16:00
1.39
0.00 (0.00%)
After-Hours: 20:00
Imunon Cash from Investing (Quarterly): -3.304M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.304M |
| September 30, 2023 | 10.67M |
| June 30, 2023 | 3.124M |
| March 31, 2023 | 0.5193M |
| December 31, 2022 | -10.88M |
| September 30, 2022 | 4.900M |
| June 30, 2022 | -2.487M |
| March 31, 2022 | 16.75M |
| December 31, 2021 | -0.9745M |
| September 30, 2021 | 3.006M |
| June 30, 2021 | -17.03M |
| March 31, 2021 | -15.12M |
| December 31, 2020 | -0.0052M |
| September 30, 2020 | 2.782M |
| June 30, 2020 | 7.096M |
| March 31, 2020 | -1.949M |
| December 31, 2019 | 2.300M |
| September 30, 2019 | 5.278M |
| June 30, 2019 | 4.355M |
| March 31, 2019 | -5.997M |
| December 31, 2018 | 4.274M |
| September 30, 2018 | -5.116M |
| June 30, 2018 | 4.950M |
| March 31, 2018 | -5.74M |
| December 31, 2017 | -12.75M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.10M |
| March 31, 2017 | 1.659M |
| December 31, 2016 | 2.825M |
| September 30, 2016 | -2.361M |
| June 30, 2016 | -2.181M |
| March 31, 2016 | 10.78M |
| December 31, 2015 | 5.969M |
| September 30, 2015 | 1.956M |
| June 30, 2015 | 3.660M |
| March 31, 2015 | 1.742M |
| December 31, 2014 | 14.64M |
| September 30, 2014 | 0.7979M |
| June 30, 2014 | 4.211M |
| March 31, 2014 | -10.10M |
| December 31, 2013 | -4.464M |
| September 30, 2013 | 10.28M |
| June 30, 2013 | -17.76M |
| March 31, 2013 | -17.20M |
| December 31, 2012 | 5.779M |
| September 30, 2012 | -2.011M |
| June 30, 2012 | 2.953M |
| March 31, 2012 | -5.250M |
| December 31, 2011 | -0.4883M |
| September 30, 2011 | -10.72M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-17.03M
Minimum
Jun 2021
16.75M
Maximum
Mar 2022
0.4748M
Average
2.300M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 0.00 |
| iBio Inc | 0.00 |
| Ocugen Inc | -2.722M |
| Petros Pharmaceuticals Inc | -- |
| Moderna Inc | 118.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.772M |
| Cash from Financing (Quarterly) | 0.0302M |
| Free Cash Flow | -19.47M |
| Free Cash Flow Per Share (Quarterly) | -0.4012 |
| Free Cash Flow Yield | -154.8% |